Sign In
Buy BOND
$91.59
-0.220 (-0.240%)
At Close: Jun 03, 2026
Silver Oak Securities Incorporated Decreases Stock Holdings in Pimco Total Return ETF $BOND
05:46am, Monday, 05'th Jan 2026
Silver Oak Securities Incorporated lowered its stake in Pimco Total Return ETF (NYSEARCA:BOND) by 79.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 3
Goldstein Advisors LLC Increases Holdings in Pimco Total Return ETF $BOND
04:44am, Friday, 02'nd Jan 2026
Goldstein Advisors LLC raised its stake in shares of Pimco Total Return ETF (NYSEARCA:BOND) by 8.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm
Wealth Manager Bets on BOND With 40,000 Shares Added
08:25am, Friday, 19'th Dec 2025
Heirloom Wealth Management added 40,231 shares, with an estimated $4.27 million increase in position value. The trade represented an approximately 9% change relative to 13F reportable assets under man
Eclectic Associates Inc. ADV Acquires 87,752 Shares of Pimco Total Return ETF $BOND
05:04am, Friday, 19'th Dec 2025
Eclectic Associates Inc. ADV lifted its holdings in Pimco Total Return ETF (NYSEARCA:BOND) by 87.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities
BOND: A Primer On This PIMCO Active Bond ETF
01:33pm, Wednesday, 10'th Dec 2025
The PIMCO Active Bond ETF (BOND) uses an active, multi-sector fixed-income approach for yield enhancement and capital appreciation. BOND has underperformed its benchmark proxy, AGG ETF, in price retur
BOND: This Active ETF From Pimco Is Still A Solid Buy
10:02am, Tuesday, 09'th Dec 2025
PIMCO Active Bond ETF (BOND) continues to deliver strong returns in 2025, outperforming typical intermediate duration fixed income vehicles. BOND benefits from a favorable macro environment, with inve
Your Advocates Dumps $19.6 Million Worth of BOND Shares
04:08pm, Thursday, 13'th Nov 2025
Your Advocates Dumps $19.6 Million Worth of BOND Shares
PIMCO's Active Bond ETF Draws Institutional Confidence in a Market That Rewards Skill
01:52pm, Wednesday, 29'th Oct 2025
Bought 87,752 shares, with an estimated transaction value of $8.10 million based on the average price for the quarter Change equals 1.49% of the fund's reportable assets under management (AUM) Post-tr
Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue sect
BOND: Reasonable Investment-Grade Bond ETF, But Too High An Expense Ratio For A Buy Rating
10:31pm, Wednesday, 22'nd Oct 2025
BOND is an actively-managed investment-grade bond ETF managed by PIMCO. PIMCO Active Bond Exchange-Traded Fund ETF compares favorably to its benchmark, somewhat unfavorably to its peers, including IGE
BOND Launches Exclusive Aviation Club for the Premium Private Flyer and Announces $350 Million Investment Led by KKR
06:00pm, Tuesday, 14'th Oct 2025
NEW YORK--(BUSINESS WIRE)--BOND, the world's first premium fractional aviation company, today announced the close of $320 million in preferred equity and debt financing led by credit funds and account
BOND: MBS Income And Flexibility
11:21am, Wednesday, 10'th Sep 2025
PIMCO Active Bond ETF offers active, diversified fixed-income exposure with a focus on risk control and long-term income and capital appreciation. Current market conditions favor agency mortgage-backe
- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Ca
BOND: Another Attractive Opportunity From Pimco
01:07am, Thursday, 19'th Jun 2025
BOND has nearly doubled its AUM to $5.5 billion in the past two years and has outperformed its actively managed peers and passive benchmark. The fund primarily invests in investment-grade MBS bonds an
GENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF "LAB 23" UNSECURED LOCAL BOND (CEBUR)
11:31am, Thursday, 12'th Jun 2025
MEXICO CITY , June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies
